eXploration Labs is located in the heart of Toronto’s Discovery District, where world-class science and discovery intersects with the dynamic energy of downtown. In this rarefied ecosystem, innovative ideas from research and biomedical companies come to life with the support of finance and business firms in the nearby Financial Core. Explore the infinite possibilities that exist in the fertile ground of this symbiotic community.
The Discovery District is home to the University of Toronto, Canada’s leading research intensive university. It is one of the top three North American institutions for medical publications and citations, a ranking that indicates its impact in the field of medical science. It also houses one of the largest Faculties of Medicine in North America, with more medical faculty and students than Harvard.
Pablum, first scientifically designed baby food
Concerned by the rate of infant mortality, Pablum was invented in 1930 by doctors Alan Brown, Theodore Drake, and Frederick Tisdall at The Hospital for Sick Children in Toronto.
Isolating T-cell and dopamine receptors
In 1984, Dr. Tak Wah Mak identified the cDNA clones encoding the human and mouse T-cell receptors, to be known as the ‘Holy Grail of Immunology’. This discovery remains the basis of research in 5,000+ laboratories around the world.
Linking insulin levels to cancer survival rates
Studies are published indicating blood insulin levels appear to be a reliable predictor of long-term survival for women with breast cancer, which women will respond well to treatment, and which are at higher risk of losing their fight against this cancer.
The heart pacemaker
In the late 1940s, revolutionizing the treatment of cardiac patients, Canadian surgeons Dr. Wilfred G. Bigelow and Dr. John C. Callaghan reached out to electrical engineer John Hopps at the National Research Council of Canada (NRC) in Ottawa to build the first pacemaker.
In 1950, the device was tested on a dog and was the first successful use of an external pacemaker in the world. In 1984, a pacemaker was implanted directly into John Hopps’ body, bridging the gap between medicine and engineering, establishing what is now known as biomedical engineering.
Revolutionizing cancer radiation treatment
In 1962, Dr. Harold E. John applied the principles of physics to medicine, leading to the development of the first Cobalt-60 Beam Therapy Unit, a revolutionary device that uses radioactive cobalt sources in the treatment of cancer, saving millions of lives.
Isolating genes for muscular dystrophy, cystic fibrosis, Alzheimer’s disease and breast cancer
In 2013, Dr. Tak Wah Mak identified a new anticancer target called PLK4, which plays a crucial role in the process of cancer cell isolation. Health Canada and U.S. FDA allow clearance to proceed with a first-in-class cancer drug to clinical trials.
Pablum, first scientifically designed baby food
Concerned by the rate of infant mortality, Pablum was invented in 1930 by doctors Alan Brown, Theodore Drake, and Frederick Tisdall at The Hospital for Sick Children in Toronto.
Isolating T-cell and dopamine receptors
In 1984, Dr. Tak Wah Mak identified the cDNA clones encoding the human and mouse T-cell receptors, to be known as the ‘Holy Grail of Immunology’. This discovery remains the basis of research in 5,000+ laboratories around the world.
Linking insulin levels to cancer survival rates
Studies are published indicating blood insulin levels appear to be a reliable predictor of long-term survival for women with breast cancer, which women will respond well to treatment, and which are at higher risk of losing their fight against this cancer.
The heart pacemaker
In the late 1940s, revolutionizing the treatment of cardiac patients, Canadian surgeons Dr. Wilfred G. Bigelow and Dr. John C. Callaghan reached out to electrical engineer John Hopps at the National Research Council of Canada (NRC) in Ottawa to build the first pacemaker.
In 1950, the device was tested on a dog and was the first successful use of an external pacemaker in the world. In 1984, a pacemaker was implanted directly into John Hopps’ body, bridging the gap between medicine and engineering, establishing what is now known as biomedical engineering.
Revolutionizing cancer radiation treatment
In 1962, Dr. Harold E. John applied the principles of physics to medicine, leading to the development of the first Cobalt-60 Beam Therapy Unit, a revolutionary device that uses radioactive cobalt sources in the treatment of cancer, saving millions of lives.
Isolating genes for muscular dystrophy, cystic fibrosis, Alzheimer’s disease and breast cancer
In 2013, Dr. Tak Wah Mak identified a new anticancer target called PLK4, which plays a crucial role in the process of cancer cell isolation. Health Canada and U.S. FDA allow clearance to proceed with a first-in-class cancer drug to clinical trials.
The heart pacemaker
In the late 1940s, revolutionizing the treatment of cardiac patients, Canadian surgeons Dr. Wilfred G. Bigelow and Dr. John C. Callaghan reached out to electrical engineer John Hopps at the National Research Council of Canada (NRC) in Ottawa to build the first pacemaker.
In 1950, the device was tested on a dog and was the first successful use of an external pacemaker in the world. In 1984, a pacemaker was implanted directly into John Hopps’ body, bridging the gap between medicine and engineering, establishing what is now known as biomedical engineering.
Pablum, first scientifically designed baby food
Concerned by the rate of infant mortality, Pablum was invented in 1930 by doctors Alan Brown, Theodore Drake, and Frederick Tisdall at The Hospital for Sick Children in Toronto.
Revolutionizing cancer radiation treatment
In 1962, Dr. Harold E. John applied the principles of physics to medicine, leading to the development of the first Cobalt-60 Beam Therapy Unit, a revolutionary device that uses radioactive cobalt sources in the treatment of cancer, saving millions of lives.
Isolating T-cell and dopamine receptors
In 1984, Dr. Tak Wah Mak identified the cDNA clones encoding the human and mouse T-cell receptors, to be known as the ‘Holy Grail of Immunology’. This discovery remains the basis of research in 5,000+ laboratories around the world.
Isolating genes for muscular dystrophy, cystic fibrosis, Alzheimer’s disease and breast cancer
In 2013, Dr. Tak Wah Mak identified a new anticancer target called PLK4, which plays a crucial role in the process of cancer cell isolation. Health Canada and U.S. FDA allow clearance to proceed with a first-in-class cancer drug to clinical trials.
Linking insulin levels to cancer survival rates
Studies are published indicating blood insulin levels appear to be a reliable predictor of long-term survival for women with breast cancer, which women will respond well to treatment, and which are at higher risk of losing their fight against this cancer.
